(-)-Baclofen
-
(-)-Baclofen
structure -
-
CAS No:
69308-37-8
-
Formula:
C10H12ClNO2
-
Chemical Name:
(-)-Baclofen
-
Synonyms:
Benzenepropanoic acid,β-(aminomethyl)-4-chloro-,(βR)-;Benzenepropanoic acid,β-(aminomethyl)-4-chloro-,(R)-;(βR)-β-(Aminomethyl)-4-chlorobenzenepropanoic acid;l-Baclofen;(-)-Baclofen;(R)-Baclofen;(R)-(-)-Baclofen;(R)-4-Amino-3-(4-chlorophenyl)butanoic acid;D-Baclofen;R-(-)-Baclofen;(R)-4-Amino-3-(4-chlorophenyl)butyric acid;Arbaclofen;STX 209;AGI 006;(R)-4-Amino-3-(4-chlorophenyl)butanoic acid;(3R)-4-Amino-3-(4-chlorophenyl)butanoic acid;2375745-79-0
- Categories:
-
CAS No:
Description
(R)-Baclofen(STX209) is a selective GABAB receptor agonist. IC50 value:Target: GABAB receptorGABAB receptors are metabotropic receptors which produce slow inhibitory signals. By manipulating GABAB receptor activity using Baclofen, a variety of functions are studied including synaptic transmissions and antinociception events.
Arbaclofen, or STX209, is the R-enantiomer of baclofen. It is believed to be a selective gamma-amino butyric acid type B receptor agonist, and has been investigated as a treatment for autism spectrum disorder and fragile X syndrome in randomized, double blind, placebo controlled trials. It has also been investigated as a treatment for spasticity due to multiple sclerosis and spinal cord injury. Arbaclofen was investigated as a treatment for gastroesophageal reflux disease (GERD); however, with disappointing results.
Characteristics
63.3
-1
1.3±0.1 g/cm3
188-189 °C @ Solvent: Hexane, Isopropanol
364.3°C at 760 mmHg
174.1±25.1 °C
1.577
2090
Store at RT
Safety Information
6.1
2811
DA8339450
P261, P264, P270, P271, P272, P280, P285, P301+P310, P302+P352, P304+P340, P304+P341, P305+P351+P338, P312, P321, P330, P332+P313, P333+P313, P337+P313, P342+P311, P362, P363, P403+P233, P405, P501
H300
|Danger|H300 (33.33%): Fatal if swallowed [Danger Acute toxicity, oral]|P261, P264, P270, P271, P272, P280, P285, P301+P310, P302+P352, P304+P340, P304+P341, P305+P351+P338, P312, P321, P330, P332+P313, P333+P313, P337+P313, P342+P311, P362, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 3 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Investigated in clinical trials as a potential treatment for spasticity in multiple sclerosis, autism spectrum disorder, and social withdrawal in fragile X syndrome.
Unlike baclofen, absorption of arbaclofen is not limited to the upper small intestine. Arbaclofen can also be absorbed in the lower small intestine and the colon, allowing for the development of sustained release formulations.|>80% of R-baclofen is renally eliminated unchanged.|Blood clearance of an IV bolus of R-baclofen in rats, monkeys, and dogs, resulted in a half life of 1.6-3.4hours, in one study. Total blood clearance was reported to be 0.51±0.13L/h/kg in rats, 0.31±0.11L/h/kg in monkeys, and 0.24±0.01L/h/kg in dogs. (2)
Arbaclofen, or R-baclofen, acts upstream of the mGluR5 receptor to increase inhibitory neurotransmission. It is the isomer of baclofen which harbors antispastic activity.
(-)-Baclofen Use and Manufacturing
R-Enantiomer of Baclofen. Specific GABA-B receptor agonist. Muscle relaxant (skeletal).
Human drugs -> Rare disease (orphan)
Computed Properties
Molecular Weight:213.66
XLogP3:-1
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:4
Exact Mass:213.0556563
Monoisotopic Mass:213.0556563
Topological Polar Surface Area:63.3
Heavy Atom Count:14
Complexity:191
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of (-)-Baclofen
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
US
6 YRS
Business licensed Certified factoryManufactory Supplier of Coenzymes,Inhibito,Enzymes,Zymogens,Substrates -
CN
5 YRS
Business licensedTrader Supplier of PVC resin,pvc paste resin,melamineInquiryCAS No.: 69308-37-8Grade: Industrial GradeContent: 99%
Latest News on (-)-Baclofen
- BMS Over $900 Million to Help Develop Potential 'Best-in-class' SHP2 Inhibitors
- AbbVie's blockbuster product for atopic dermatitis, Upadacitinib, has been approved for marketing in the EU and Japan
- Designing peptide inhibitors for possible COVID-19 treatments
- Chinese scientists discover the inhibitors of SARS-CoV-2
Learn More Other Chemicals
-
Dabrafenib
1195765-45-7
-
BOC-VAL-VAL-OH
69209-73-0
-
BMS 303141
943962-47-8
-
(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanamide Formula
60117-17-1
-
(2S)-2-acetamido-6-amino-N-[(2S)-2-amino-3-methylbutanoyl]-N-propylhexanamide Formula
57899-96-4
-
1-(6-methoxy-1,3-benzothiazol-2-yl)-3-phenylurea Formula
26130-02-9
-
L-Tyrosyl-L-phenylalanine Structure
17355-11-2
-
C-REACTIVE PROTEIN FRAGMENT 77-82 Structure
130349-01-8
-
What is Sildenafil
139755-83-2
-
What is Dacomitinib
1110813-31-4